Skip to content
Search

Latest Stories

Titan PMR receives NHS accreditation to provide electronic prescription services

Titan PMR has been accredited by the NHS to provide electronic prescription services (EPS) to dispensing doctors.

Over 1,000 of these doctors, who provide a vital service to almost 10 million people in rural communities, can now offer their patients the same level of benefits and efficiencies that electronic prescriptions and Titan PMR have brought to pharmacies around the UK.


These features will also increase efficiency for dispensing doctors, who will reduce dispensing errors and improve organisation, increasing their capacity while enjoying the ability to integrate with other technologies.

After a full year of testing, including six months of compliance testing at a practice in Cumbria, the new accreditation for Titan also has potential to help the NHS fulfil its target of all prescriptions being issued electronically.

Currently written paper prescriptions from dispensing doctors account for around seven per cent of the total prescriptions in England – around 6.5 million each month.

“Until now dispensing doctor surgeries have basically been in the digital dark ages when it comes to dispensing medicines,” said Tariq Muhammad, a tech entrepreneur and CEO of Bristol-based Invatech Health, which developed Titan PMR.

“What this accreditation means is that surgeries can deliver a more efficient and safer service to their patients, with doctors able to spend less time pushing paper and more time speaking to people and helping with their problems.

“All this builds patient loyalty and stops the loss of dispensing income that makes these rural surgeries sustainable.

“For the NHS, digital dispensing of medicines is like taking away the final blockage from a dam that’s ready to burst. Our system can dramatically help with better dispensing processes. We’re already administering one in 20 prescriptions in the country and that figure’s growing every day.

“Of course for us as a business, with 1,000 dispensing doctors in England and with no viable alternatives to our system, it’s got great potential as a growth area.

“We just want to help bring the benefits of technology to every sector where medicines are dispensed. Everybody wins – patients, our communities, the NHS, pharmacists and now dispensing doctors too.”

In late 2019 Titan became the first new patient medication record (PMR) system to be accredited by the NHS in more than a decade.

With its innovative barcode, cloud-based technology it is revolutionising the pharmacy industry and has been adopted en masse in community pharmacies and the disruptive online sector.

Since deployment it has grown rapidly and now processes more than five per cent, or four million per month, of all prescriptions in the UK. The number is expected to double in the next year.

In March 2021, Titan it helped create the UK’s first entirely paper-free pharmacy, in Sheffield. It has won contracts with the fastest growing online pharmacies in the country and helped cut dispensing errors at some locations by up to 95 per cent.

Laura Wright is the manager of Stoneleigh Surgery in Milnthorpe, Cumbria, where Titan was tested in a dispensing doctor surgery.

“With multiple surgery locations, each of which are able to generate prescriptions, we were keen to start working with EPS,” she said. “Paper prescriptions would often not be available when patients came into the dispensary but now, they are immediately available at the surgery.

“There’s an increased level of safety, and it’s much easier to find what stage the patient’s medication is at. We’re already finding that patients love the improved service that we offer from our dispensary, which is good for our community and offers us greater potential to further enhance our service.”

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less